BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khanam SS, Son JW, Lee JW, Youn YJ, Yoon J, Lee SH, Kim JY, Ahn SG, Ahn MS, Yoo BS. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure. BMC Cardiovasc Disord 2017;17:215. [PMID: 28774268 DOI: 10.1186/s12872-017-0632-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Chan JSK, Kot TKM, Ng M, Harky A. Continuous Infusion Versus Intermittent Boluses of Furosemide in Acute Heart Failure: A Systematic Review and Meta-Analysis. J Card Fail 2020;26:786-93. [PMID: 31730917 DOI: 10.1016/j.cardfail.2019.11.013] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Radhachandran A, Garikipati A, Zelin NS, Pellegrini E, Ghandian S, Calvert J, Hoffman J, Mao Q, Das R. Prediction of short-term mortality in acute heart failure patients using minimal electronic health record data. BioData Min 2021;14:23. [PMID: 33789700 DOI: 10.1186/s13040-021-00255-w] [Reference Citation Analysis]
3 Wang X, Guo D, Li W, Zhang Q, Jiang Y, Wang Q, Li C, Qiu Q, Wang Y. Danshen (Salvia miltiorrhiza) restricts MD2/TLR4-MyD88 complex formation and signalling in acute myocardial infarction-induced heart failure. J Cell Mol Med 2020;24:10677-92. [PMID: 32757377 DOI: 10.1111/jcmm.15688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Wang Z, Dong Y, Gao Q, Zhang Q, Jiang H. The role of acute heart failure index (AHFI) combined with emergency heart failure mortality risk grade (EHMRG) in the evaluation of clinical outcomes and prognosis in patients with acute heart failure. Acta Cardiol 2021;:1-6. [PMID: 34338593 DOI: 10.1080/00015385.2021.1955482] [Reference Citation Analysis]
5 Romuk E, Jacheć W, Zbrojkiewicz E, Mroczek A, Niedziela J, Gąsior M, Rozentryt P, Wojciechowska C. Ceruloplasmin, NT-proBNP, and Clinical Data as Risk Factors of Death or Heart Transplantation in a 1-Year Follow-Up of Heart Failure Patients. J Clin Med 2020;9:E137. [PMID: 31947878 DOI: 10.3390/jcm9010137] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Huang S, Peng W, Yang N, Yu T, Cui HY, Xu JY, An Q, Yang H, Liu YN, Li Z, Zuo MZ. Myocardial injury in elderly patients after abdominal surgery. Aging Clin Exp Res 2018;30:1217-23. [PMID: 29435832 DOI: 10.1007/s40520-018-0908-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci 2019;20:E1820. [PMID: 31013779 DOI: 10.3390/ijms20081820] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 13.7] [Reference Citation Analysis]
8 Jiang Z, Fu L, Xu Y, Hu X, Yang H, Zhang Y, Luo H, Gan S, Tao L, Liang G, Shen X. Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses. Sci Rep. 2020;10:6427. [PMID: 32286474 DOI: 10.1038/s41598-020-63498-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Takashio S, Takahama H, Nishikimi T, Hayashi T, Nagai-Okatani C, Matsuo A, Nakagawa Y, Amano M, Hamatani Y, Okada A, Amaki M, Hasegawa T, Kanzaki H, Yasuda S, Kangawa K, Anzai T, Minamino N, Izumi C. Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms. Open Heart 2019;6:e001072. [PMID: 31413847 DOI: 10.1136/openhrt-2019-001072] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Pan D, Xiao S, Hu Y, Pan Q, Wu Q, Wang X, Liu Q, Liu A, Liu J, Zhu H, Zhou Y. Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention. Cardiovasc Ther 2021;2021:3758320. [PMID: 34987604 DOI: 10.1155/2021/3758320] [Reference Citation Analysis]
11 Wehbe RM, Khan SS, Shah SJ, Ahmad FS. Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure. Heart Fail Clin 2020;16:387-407. [PMID: 32888635 DOI: 10.1016/j.hfc.2020.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Koleini N, Nickel BE, Nagalingam RS, Landry NM, Fandrich RR, Cheung DYC, Dixon IM, Czubryt MP, Jassal DS, Cattini PA, Kardami E. Elimination of endogenous high molecular weight FGF2 prevents pressure-overload-induced systolic dysfunction, linked to increased FGFR1 activity and NR1D1 expression. Cell Tissue Res 2021. [PMID: 34057573 DOI: 10.1007/s00441-021-03465-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Pölzl G, Allipour Birgani S, Comín-Colet J, Delgado JF, Fedele F, García-Gonzáles MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Vrtovec B, Wikström G, Altenberger J. Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period. ESC Heart Fail 2019;6:174-81. [PMID: 30378288 DOI: 10.1002/ehf2.12366] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
14 Ning Y, Wei M, Song W, Luo G. The Relationship Between Atrial Cardiopathy Biomarkers and Prognosis of Patients With Embolic Stroke of Undetermined Source. Front Cardiovasc Med 2022;9:829361. [DOI: 10.3389/fcvm.2022.829361] [Reference Citation Analysis]
15 Gtif I, Bouzid F, Charfeddine S, Abid L, Kharrat N. Heart failure disease: An African perspective. Arch Cardiovasc Dis 2021;114:680-90. [PMID: 34563468 DOI: 10.1016/j.acvd.2021.07.001] [Reference Citation Analysis]
16 Oikonomou E, Vogiatzi G, Tsalamandris S, Mourouzis K, Siasos G, Lazaros G, Skotsimara G, Marinos G, Vavuranakis M, Tousoulis D. Non-natriuretic peptide biomarkers in heart failure with preserved and reduced ejection fraction. Biomark Med 2018;12:783-97. [PMID: 29865857 DOI: 10.2217/bmm-2017-0376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
17 Dahiya T, Yadav S, Yadav N, Mann A, Sharma M, Rana J. Monitoring of BNP cardiac biomarker with major emphasis on biosensing methods: A review. Sensors International 2021;2:100103. [DOI: 10.1016/j.sintl.2021.100103] [Reference Citation Analysis]
18 Cao Z, Zhao M, Xu C, Zhang T, Jia Y, Wang T, Zhu B. Evaluation of Agonal Cardiac Function for Sudden Cardiac Death in Forensic Medicine with Postmortem Brain Natriuretic Peptide (BNP) and NT‐proBNP: A Meta‐analysis. J Forensic Sci 2020;65:686-91. [DOI: 10.1111/1556-4029.14232] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Pourafkari L, Tajlil A, Nader ND. Biomarkers in diagnosing and treatment of acute heart failure. Biomark Med 2019;13:1235-49. [PMID: 31580155 DOI: 10.2217/bmm-2019-0134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Lee JW, Choi E, Khanam SS, Son JW, Youn YJ, Ahn MS, Ahn SG, Kim JY, Lee SH, Yoon J, Yoo BS. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction. Int J Cardiol 2019;289:19-23. [PMID: 30638981 DOI: 10.1016/j.ijcard.2019.01.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
21 Uyar H, Yesil E, Karadeniz M, Orscelik O, Ozkan B, Ozcan T, Cicek Yilmaz D, Celik A. The Effect of High Lactate Level on Mortality in Acute Heart Failure Patients With Reduced Ejection Fraction Without Cardiogenic Shock. Cardiovasc Toxicol 2020;20:361-9. [PMID: 32048133 DOI: 10.1007/s12012-020-09563-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]